L7|ESP® for Academic Research + NCI Designated Cancer Centers

improving patient outcomes

For Academic Research and NCI Designated Cancer Centers involved in Research and Advanced Therapeutics, L7|ESP enables these organizations to focus on the clinical pathways and treatment protocols while automating and streamlining all the workflows and data capture across the clinical pathway in a regulatory-compliant platform (CAP/CLIA/cGMP/21 CFR part11 and HIPAA). L7|ESP integrates with scientific instruments, medical devices, imaging systems, EMR, ERP, lab informatics, and digital pathology systems to provide end-to-end tracking of patient treatment with complete audit and decision support capabilities.

research

Research is a cornerstone of the healthcare industry, driving advancements in medical knowledge and patient care. L7|ESP offers comprehensive support to cancer centers and research institutions, providing a unified platform for efficient data management, analysis, and collaboration. From conducting clinical trials to studying disease patterns and exploring innovative treatment approaches, L7|ESP streamlines the research process and empowers institutions to accelerate discoveries.

With L7|ESP, Academic Research + NCI Designated Cancer Centers can seamlessly integrate and organize diverse datasets from various sources, including genomics, proteomics, and clinical information. The platform’s advanced analytics tools enable researchers to uncover meaningful insights, identify correlations, and discover potential biomarkers. By facilitating collaboration and data sharing among multidisciplinary research teams, L7|ESP drives collaborative breakthroughs and enhances the translation of research findings into clinical practice.

L7|ESP empowers cancer centers and research institutions in their pursuit of groundbreaking discoveries. By offering a unified platform for data management, analysis, and collaboration, L7|ESP streamlines research processes and accelerates the translation of findings into clinical practice. With L7|ESP’s advanced analytics tools and seamless data integration, health systems can drive interdisciplinary collaboration, uncover meaningful insights, and make significant contributions to advancing medical knowledge and improving patient care.

supporting case studies

Connect with the L7 Team to find out more about the work we did with The Jackson Laboratory and WashU.

advanced therapeutics

Academic Research + NCI Designated Cancer Centers play a pivotal role in the development and delivery of advanced therapeutics, revolutionizing patient treatment options. L7|ESP supports them in this field by providing robust data management and analysis capabilities. From cell and gene therapies to immunotherapies, L7|ESP facilitates the complex data handling and processing required for advanced therapeutic research and implementation.

By integrating and analyzing diverse data types, such as genomics, patient outcomes, and treatment responses, L7|ESP empowers cancer centers and research institutions to identify biomarkers, predict treatment efficacy, and optimize therapeutic approaches. The platform’s customizable workflows and automated pipelines enhance the efficiency of advanced therapeutic development and manufacturing, enabling health systems to accelerate the translation of research into clinical applications.

L7|ESP empowers Academic Research + NCI Designated Cancer Centers to drive innovation and advancements in advanced therapeutics. By providing robust data management and analysis capabilities, L7|ESP enables health systems to integrate diverse datasets, identify biomarkers, and optimize therapeutic approaches. With L7|ESP’s customizable workflows and automated pipelines, health systems can streamline the development and manufacturing of advanced therapeutics, accelerating the translation of research into clinical applications. L7|ESP plays a pivotal role in the progress of health systems, empowering them to deliver cutting-edge therapies and improve patient outcomes.

supporting case studies

Connect with the L7 Team to find out more about the work we did with Dana Farber Cancer Institute and Rutgers Cancer Institute of New Jersey.